Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy

Food and Healthcare Press Releases Tuesday March 13, 2018 15:30
BANGALORE, India--13 Mar--PRNewswire/InfoQuest

A new study published in the international Nature Eye Journal demonstrates very high sensitivity for detecting Diabetic Retinopathy (DR) (95.8%) and Sight-threatening DR (99.1%) using Remidio's Fundus on Phone (FOP) device - an FDA 510k registered and CE marked smartphone-based retinal imaging device and Eyenuk's EyeArt Artificial Intelligence algorithm

Diabetes, a problem affecting more than 422 million globally, may lead to a sight-threatening condition called Diabetic Retinopathy (DR). 90% of the vision loss due to DR is preventable by early detection and timely treatment. Screening for DR has not been possible primarily due to two key challenges: (a) High Cost of Retinal Imaging Devices (b) Lack of access to specialist eye doctors, e.g., only 15,000 specialists are available to screen more than 70 million diabetics in India.

(Logo: https://mma.prnewswire.com/media/652990/Remidio_Logo.jpg )
(Photo: https://mma.prnewswire.com/media/652991/Remidio_Fundus_on_Phone.jpg )

Remidio Innovative Solutions based in Bangalore, India has disrupted the field of retinal imaging with their high quality, portable devices. The   Remidio Fundus on Phone (FOP) that works on smartphones, weighs 1/20th the size of conventional systems, costs just 1/5th the price, and can image without pupil dilation.

Until recently, DR could only be detected by ophthalmologists and trained graders. Artificial intelligence (AI), can now be employed to grade retinal images, especially those with sight-threatening DR.

In a study done at Madras Diabetes Research Foundation (MDRF), Chennai, and published by   Nature Eye , retinal photographs were taken on diabetics using the Remidio FOP, (previously validated to have a clinical sensitivity of 93% and specificity of 98%) and graded by ophthalmologists as well as by the AI algorithm EyeArt. This study showed that, the use of EyeArt automated AI along with Remidio Fundus on Phone (FOP) has very high sensitivity for detecting Diabetic   retinopathy (95.8%) and sight-threatening DR (99.1%). This is possibly the first study that has looked at the role and accuracy of automated Artificial Intelligence (AI) based DR detection in smartphone based retinal imaging.

Dr. Anand Sivaraman, CEO of Remidio Innovative Solutions Pvt. Ltd., said, "The simplicity of use of Remidio's smartphone based Fundus on Phone when combined with Artificial Intelligence like EyeArt, may now enable large scale public health screening for Diabetic Retinopathy globally."

For press queries contact:
Dr. Anand Sivaraman
+91-9845155475
anand@remidio.com
Source: Remidio Innovative Solutions

Latest Press Release

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Related Topics